Eli Lilly and Co.'s purchase of Centessa Pharmaceuticals for $6.3 billion upfront is the latest in a string of deals ...

Overview BiPC students now have diverse career paths beyond MBBS, including research and technology.High-paying non-NEET ...

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the ...

Biogen (Nasdaq: BIIB) is acquiring Waltham-based Apellis Pharmaceuticals Inc. (Nasdaq: APLS) for $5.6 billion as it continues ...

Streamlining clinical trials, harmonising regulations and improving access to capital should be driving biotech efforts, ...

Samarth Kulkarni is one of the most consequential figures in modern biotechnology, widely recognised for his role in transforming CRISPR Therapeutics from an early-stage gene-editing company into the ...

Resident companies now have free access to specialized trainings, HR office hours, and community perks CAMBRIDGE, Mass., March 31, 2026 /PRNewswire/ -- LabCentral today announced a new suite of human ...

As the Trump administration cracks down on the H-1B visa program, which allows skilled workers like software engineers to ...

Strengthening British Columbia's life sciences sector by supporting projects that advance emerging Canadian technologies and enhance the innovation ecosystem VANCOUVER, BC, April 2, 2026 /CNW/ - Today ...

If you drive long enough in West Virginia during the bare, gray winter months — when there is no foliage to obscure the view of mangled mountaintops and bare hillsides — you can’t help but notice ...

Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada.

As the Trump administration cracks down on the H-1B visa program, which allows skilled workers like software engineers to ...